Table 1.
Descriptive analysis: patients and tumors characteristics.
| Patients and tumors characteristics | N° patients (%) |
|---|---|
| Risk factors | |
| • No risk factor | 69 (50.4) |
| • Alcoholic cirrhosis | 6 (4.4) |
| • Biliary lithiasis | 15 (11) |
| • Viral hepatitis | 24 (17.6) |
| • Cholangitis | 6 (4,4) |
| • Asbestos exposure | 4 (3) |
| • Smoke | 10 (7.3) |
| • Smoke and viral hepatitis | 1 (0.7) |
| • Smoke and alcoholic cirrhosis | 2 (1.4) |
| Primary site | |
| • ICCA | 88 (64) |
| • ECCA | 18 (13) |
| • GBC | 19 (14) |
| • Unknown site | 12 (9) |
| First-line chemotherapy | |
| • Cisplatin plus gemcitabine | 24 (17.5) |
| • Oxaliplatin plus gemcitabine | 39 (28,5) |
| • Others | 66 (48) |
| • Unknown | 8 (6) |
| Surgery | |
| • No surgery | 80 (58.4) |
| • R0 | 35 (25.5) |
| • R1 | 14 (10.2) |
| • R2 | 5 (3.6) |
| • Unknown | 2 (2.3 ) |
| Loco-regional treatments | |
| • No treatments | 128 (93.4) |
| • Thermo-ablation | 3 (2,2) |
| • Chemoembolization | 4 (3) |
| • Yttrium-90 | 1 (0.7) |